-
8/10/2019 SLE 2008 -1
1/14
MARCH
SLE 2008COLLECTED AND TRIED TO BE ANSWERD AND SENT
BYDR.ABULMALIK ALBAKER [email protected]
1 ,')*+,-./*,- )*+,-.)'&%$#"!*-,3-*3435'"6!79:%;!???
@. ),* -. BD .- ). 3- F.#GI>J!K!N
OP2 Q:'+,T,@343OGUV5W=>XVYZ>!X![#5\#QN*T.5_`>
-
8/10/2019 SLE 2008 -1
2/14
ET*-)*, .D.3 Q,est felt than see T- .-/painful red nodules
treated ,y S1./s
2346766896;*?@=6
44-4, } 4 3, g.* .g3-T/-4. QArectB CDRA -AST E F supine
a,dominal GH ray
)4'I6J?K6L
/)4D 4-) */*, ,T* + )* 43 . 3-*T.4D ,D ),4k 4-/)4k D43-Tg
)433**+4k@ ,3*T -. k4* ,-4)43-,4* .T 3-*T.4D /T*, vv
6M6N+2O6Q846'*U=6V*='if angioedema HHH epinephrine~.D 3-,D,TD
4,k4k 4 ,/-* +,/*T4,-4-43 Q'W9 XT scan if less than YZh no value d[
on clinical and al,s
+T*k,- ,D@ 28 F3 4-) /),@D, 4|*/-4. Q
a\ithromycin not pregnanterythromycin in pregnant ,est ] treat
partners if amo[ B,estEdo[cyline not pregnant
/.. /,3* .| ,* 4|*T-44-@Q The most common cause is a low sperm
countprimary hypogonadism most common cause is ^linefeter syndrome
Y_[[ysecondary hypogonadisme`aculation o,structionThe mos !ommo"
congenital!#$se %s K&%"e'e&e( s)"*(ome
18@*,T3 .D g.@ 4-) g,/F +,4 4*3-4k,-4. -. D. *}/*+- QX-X #ASRG
Hray,one scanif lytic lesion ,one scan is ,est
4T. D*B/4*/@ ,*,4, Qserum iron
ferritin B dierence ,t chronic anemia HT.-X,one marrow B ,est if
not there ferritin E
H@+.-)@T.4D434 Qfree TYTSbTY
-
8/10/2019 SLE 2008 -1
3/14
4 )4/) kT.+ @. 4 D. .*T *D.3/.+@ |.T +,-4*-3 4-) 4T.
D*B/4*/@,*,4, 4 4-) . g*4k /,3*Qmale all age
groupchildrenpermanupausal women & male more than 59 ywomen
DXP
=2346)6
/)4D 4-) +4*/* .| k,33 g*,3 g,--*T@ D**+ 4 *,T /,, ),- -. D.Qno
irrigation ,,,,,, , best pick with forceps34D* **/-3 .| L*.D.+,
Qdys^inesiaspeechfatal hepatic to[icity""#
A+"o(m#& h%",%"- ho&*%"- '#&se +e&%e's h# !#""o
+e !h#"-e* +) '#! A-%#%o" A"/%e)
C&e"!h%"- o( -(%"*%"- o' eeh C&$ms%"ess o( $"se#*%"ess
Co"'$s%o"D%''%!$&) s#&&o%"- D%%"ess E/!ess%e #e(%"- o'
mo$h 3#&se se"se o' e&& +e%"- 3ee&%"- '#%"
4e"e(#& 'ee&%"- o' *%s!om'o( o( %&&"ess
H#&&$!%"#%o"s 5see%"-6 he#(%"-6 o( 'ee&%"- h%"-s h# #(e
"o he(e7 H#"* (emo(6 %"!(e#se*
N#$se# o( om%%"- N$m+"ess
1b +,-4*- )4* )* +,@4k |..- g, -)*T* 43 .* /.* +.+ )43 F**
|T.-)* ,-*T, 34D* /.* -. -)* ).3+4-, ),- 43 -)* .3- +T.g,g@ /- 4T@
.//TvHmedial collateral ligament
#&-$s 'o(!e #88&%e* o # '&e/e* ,"ee m#) !#$se # e#(
o' he me*%#& me"%s!$s. A #($s 'o(!e o" # '&e/e* ,"ee %h
he'em$( e/e("#&&) (o#e* m#) &e#* o # e(#& me"%s!$s
&es%o". A!!o(*%"- o R%!,&%"6 he me*%#& me"%s!$s %s
##!he* mo(e'%(m&) h#" he (e%e&) mo+%&e e(#&
me"%s!$s6 #"* h%s m#) (es$& %" # -(e#e( %"!%*e"!e o' me*%#&
me"%s!$s %"$().
2b .T -)43 /,3* -)* -T*,-*- 43Q1H conservativeACLQ R*3-3 |T. ,
./.-,/- -43-4k */),43 |.T/*D )@+*T*}-*34. .T4+,/- -. , *}-*D*D F**
,-*T4.T DT,*T ,D L,/), -*3-3 R* .- ,*43/, .T MCL 4T@CLQ R*3-3 |T.
|.T/*D )@+*T*}-*34. +.3-*T4.T DT,*T -*3- M*43/, -*,T3 Q R*3- |T. ,
,/-* -43-4k 4T@ C4/F4k .T ./F4k ,@ g*+T*3*- E}, 3).3 .4- 4*
-*D*T*33 ,D , M/MTT,@3 -*3-
-
8/10/2019 SLE 2008 -1
4/14
ab o0 .T oo +,-4*- +T*3*- 4-) 4,-*T, 3).D*T ++*T .*T 4++,4 4-)
.T4k 3-4*33 .| .T* 4-*34-@ ,|-*T ,F* + -)*T* 43 4D|**T -)* +,-4*-
43 D*+T*33*D Q4,k.343Q1HR"1-H Polymyalgia rheumatic ASR"
rb M,* +,-4*- F. /,3* .| M /.* 4-) Hg A1C Q 8 )* 43 -,F4k
*-|.T4 k4g*/,4D -. T*k,-* -)* g..D 3k,T **D Q1H
""""""""""""insulin-H""""""""""""insulinXH metformin F acar,ose
"
ob /,3* 3/*,T4. +,-4*- +T*3*- 4-) /.3-4+,-4. } Q )@+.-)@T.4D43.
/.BT -),- -)* +,-4*- ),3 )@+.-)@T.4D43Q1HTY-HTSbXHfree TY
b C,3* 3/*,T4. +,-4*- +T*3*- 4-) 3@+-.3 .| )@+*T-)@T.4D43-*D*T
*/F 3*4k Q4,k.343Qsu,acute thyroiditis -T,-*D 4-) SA A SER
b .-)*T gT4k )*T g,g@ -. @. )* 3)* /.+,4 .| D4,+*T T,3) 3)**- -.
D4*T*- DTk g*|.T* 3)* /.* -. @. 3)* 3*D a D4*T*-/.T-4/.3-*T.4D DTk
+T*3/T4g*D g@ D4*T*- +)@34/4,
-)* T,3) 43 * D*,T/,-*D 3/,@ Q4,k.343Q
1Hse,orrheic dermatitis-Hcontact dermatitis include la,i wheras
candida notXH#
b )* -T*,-*-Qvv,.4D ,*Tk* ,D 3-*T.4D |.T /.-,/- D*T
8b |*,* +,-4*- ,k*T 34/* 3).T- -4* g*/.* D*+T*33*D 3)* 3,4D3)*
/,- ,,k* -)* /.4/-3 -),- ),++* 4 -)* .TF g*-**
-)**+.@**34,k.343Q
1H/epression"-Hjenerali\ed an[iety disorder"XH1d`ustment
/isorders
b C,3* 3/*,T4. |*,* +,-4*- +T*3*- 4-) *}/*334* |*,T 4 )*T/)4DT*
@ .+44. 4- 43 , /,3* k**T,4*D ,}4*-@ D43.TD*TT*,-*-Qv
-
8/10/2019 SLE 2008 -1
5/14
10b ,-4*- g*|.T* *3-T,-4. g@ 2ba D,@3 +T*3*- 4-) D*+T*33*D
..D-),- D43,++*,T g@ 2ba D,@ ,|-*T -)* g*k44k .|
*3-T,-4.4,k.343Q1HPremenstrual dysphoric disorder if sever symptoms
Bor premenstrualsyndrome #E"
11b *,* +,-4*- gT*,3- |**D4k +T*3*- 4-) ,3-4-43 4 ++*T .-*T
,DT,-QT*,-*-Q1Hstope ,reast feeding F evacuate the mil^ ,y the
,reast pump"-H jive"""""anti,iotic to the mother F anti,iotic to
the ,a,y"cH anti,iotics with continue ,reast feeding
12b /,3* 3/*,T4. g,g@ +T*3*- 4-) 4,-*T, D*|.T4-@ 4 -)*
|..-,++*,T )* 4- 43 g*/.* -)* *4k)- g*,T4k 43 4 -)* .-)*T |..- g-
)*4- 43 -)* *4k)- g*,T4k -)* D*|.T4-@ D43,++*,T -)* +,-4*- ),3
D*|*/- 4D.T34*}4. .| -),- |..- -)4F -)*@ ,T* -,F4k ,g.- /g |..-
-T*,-*- Q
1Horthopedic correction """#-Hshoe""""XHsurgery """"
TE: %s !#$se* +) -e"e%!'#!o(s s$!h #s E*#(*s s)"*(om18
/)T..3.*se(%#& !#s%"-6 o( s8&%"s !#&&e* ,"ee
#",&e 'oo o(hoses 5KA3O7 '%(s %' "o (es8o"s 6 s$(-e().
1ab /,3* 3/*,T4. +,-4*- +T*3*- +,-*T |,3/4-43T*,-*-Q g*3- 4-) SA
HE SER H AH1HXorticosteroid in`ection"-Hsilicon"""
1rb ,-4*- +T*3*- 4-) T*-4, ,T-*T@ .//34. )4/) 43 T.kQ1H Painful
loss of vision"-HH Painless loss of vision"
1ob ,-4*- +T*3*- 4-) /.T*, ,gT,34.QT*,-*-Q1HXover the eye with a
dressing"-H1nti,iotic ointment put it in the home without covering
the eye#
1b ,-4*- +T*3*- 4-) *+43-,}43Q)* g*3- ,,k**-Q
H the patient leaning forward ma^e pressure in the lower side of
the nose "1b ,-4*- +T*3*- 4-) 4,-*T, ,3, D43/),Tk* |. 3*4k 4 -)*
.3* M.3- +T.g,g@ D4,k.343QH 1denoidH koreign ,odyThe 8(ese"!e o'
unilateral foul smelling nasal discharge%s #)s #" %"*%!#%o" o'
'o(e%-" +o*) %" he nose
b 18 .-)3 g,g@ +T*3*- -),- )* .@ 3,@4k ,, g,g, )4/) 43,g.T, |.T
)43 ,k* . .-)*T 3@+-.3 .T 34k ,g.T, BT3- -)4k -.
http://en.wikipedia.org/wiki/Geneticshttp://en.wikipedia.org/wiki/Edwards_syndromehttp://en.wikipedia.org/wiki/Geneticshttp://en.wikipedia.org/wiki/Edwards_syndrome
-
8/10/2019 SLE 2008 -1
6/14
g* ,33*3 QH Hhearing assessment "H Hdevelopmental assessment
"
1b C,3* 3/*,T4. /)4D +T*3*- 4-) T)4.TT)*, 3.T* -)T.,- |.T o
D,@3+T*3*- 4-) 4DD* *,T +*T|34. *},4,-4. .| -)* *,T Q . T*D*33 4-)*
*,T-)* /,3* .| +*T|34. Q
H otitis media ,ecause no pain "H pper respiratory infection"20
C,3* 3/*,T4. +,-4*- F. /,3* .| /.T.,T@ ,T-*T@ D43*,3* +T*3*-4-) ,
3@+-.3 .| 4- -. D4,k.3* -),- +,-4*- ),3 M .T .- g@ rst AXjand
X1R/.1X ACA1H A[ercise stress test "-H Xoronary angiographyXH
A[ercise""""
21b ,-4*- +T*3*- 4-) ,/-* +T*/,TD4-43 EC~ * 3** ECE Qb Sb 3*k*-
**,-4.
Hq wavesHprolonged PR interval b - ,* 4*T34. 3- **,-4.
22b/,3* 3/*,T4. +,-4*- +T*3*- 4-) /,T.-4D ,T-*T@ .g3-T/-4. g@
80-T*,-*- g@H carotid endarterectomy"H """"""""surgical ,ypass.f
more than _0 % go to surgery
2ab ,-4*- +T*3*- 4-) k**T,4*D 3*4T*3 .- F. /,3* g*|.T* .|,@ 34*T
. +*T4.3 )43-.T@ 4F* -),- Q
)* .3- 4+.T-,- -)4k -. D. . 43QH AAj" 1fter thatH a,oratory test
"in AR
.f sei\ures are newHonset or if e[amination results are a,normal
for the rst timeneuroimaging is required"AAj is less li^ely to
detect a,normalities if sei\ures are
infrequent"Alectroencephalograms are an important tool in
determining prognosis for futuresei\ures and should ,e strongly
considered for all children with a rst sei\urethe AAj will ,e
normal in 50% of patients following a rst sei\ure
2rb C,3* 3/*,T4. +,-4*- +T*3*- 4-) /,T+, -*
3@DT.*T*,-*-QHcorticosteroid in`ection
Splint the wrist in a neutral position at night and during the
day if possi,le"1dminister S1./s"Xonservative treatment can include
corticosteroid in`ection of the carpalcanal" H XTS"- they didnt
mention a surgery in the CX
2ob/,3* 3/*,T4. +,-4*- +T*3*- 4-) SLE
-
8/10/2019 SLE 2008 -1
7/14
)* *,3- DTk ),3 34D* **/-QH methotre[ateH name of other
chemotherapy
2b /,3* 3/*,T4. +,-4*- +T*3*- 4-) +T.3-,-4-43 g@ /-T* kT,*k,-4*
T.D* -T*,-*- Q
H Trimethoprim and Sulfametho[a\ole or urqunilonesH ampicillin
if suspected sepsis with gentamicinH gentamicin if suspected sepsis
with ampicillin
2b /,3* 3/*,T4. +,-4*- +T*3*- 4-) R ,|-*T 1 **F -)* +,-4*-+T*3*-
-. ),* )*,-T4, *D*, .3- +T.g,g@ D4,k.343QH .g1 nephropathyH post
streptococcus j
Postinfectious glomerulonephritis : Dliguria edema
hypertensionteaH or colaHcoloredurine" !H wee^s ttt supprtive
.g1 nephropathy : hematuria ormal X ttt : jlucocorticoids
28b -)* .3- 4+.T-,- D4,k.3-4/ -*3- |.T -),- 43 Qb Cicroscopic
R-XHCacroscopic R-X"H R-X cast"
2b /,3* 3/*,T4. +,-4*- F. /,3* .| )@+*T/).*3-*T*4, M Qa1T*3*-
4-) 4*3-4k,-4. 3).4k g*T3 Q)4k) -.-, /).*3-*T. )4k)LL )4k) ~
| -)*3* 4*3-4k,-4. ),- 43 -)* D,k*T .* |.T D**.+4k /.T.,T@
,T-*T@D43*,3 QH/
Total cholesterol !00 mgd / 0 mgd triglycerides 500 mgd and b/ x
Y0 mgd are ris^ factors for X1/
a0b C,3* 3/*,T4. +,-4*- +T*3*- 4-) ,/-* +,/T*,-4-43 g*3-
D4,k.343 g@ QH CR.H Xontrast computed tomographyH GHray
a1b C,3* 3/*,T4. +,-4*- +T*3*- 4-) a D,@3 )43-.T@ .| g**D4k +*T
T*/- +T*3*- .| +,4 ,|-*T D*|*/,-4. g@ *},4,-4. ,33 ,- a ././F
QT*,-*-Q1HPut a sit\ ,ath 5 time a day "-H S1./ ointment locally
"XH ligate the mass then remove it "
1cute kissurevery painful ,right red ,leeding especially after
,owel movementtreatment is conservative: stool softeners sit\
,aths
-
8/10/2019 SLE 2008 -1
8/14
a2b /,3* 3/*,T4. |*,* +,-4*- +T*3*- 4-) T-4/,T4, -)*T* 43 ,
)43-.T@ .|3*4k 4 -)* 4+ 3.* -4*3 D4,k.343 Q4,k.343QH angioedema
####around mouth
aab ,g.- +*+-4/ /*T ). -. F. 4| 4- 43 D* [email protected] .T .-
arb +,-4*- @.T D4,k.343 |.T )* 43 /,/*T ). -. gT*,F -),- g,D
*|.T )* QH see the patient how many ^now a,out the disease"b
aob oo ,* +,-4*- +T*3*- |.T /)*/F + +)@34/, *},4,-4. 43 .T,,g
4*3-4k,-4. 4/T./@-4/ )@+./)T.4/ ,*4, Hg Q-)* .3- 4F*@ /,3* -. *}/D*
43H lymphoma"H gastroenterology malignancy"b
ab+,-4*- ). 43 3.F*T -)* *,3- D43*,3* -. .//T 4 )4 43 QHrinary
cancer"H Xolon cancer"
ab /,3* 3/*,T4. +,-4*- +T*3*- 4-) ,/-* 3@+-.3 .| g..D@ D4,TT)*,
4,k.343 ,/-* /*T,-4* /.4-43 Q-)* 44-4, -T*,-*- |.T -)43 +,-4*-
QHcorticosteroid therapy "H methotre[ate"H 5H1minosalicylic
acidHsulfasal\ine
a8b T*k,- .* +T*3*- 4-) , ,33 4 )*T .-) g**D4k )* gT3)
)*T-**-)g@ *},4,-4. ,33 a}2 / D4,k.343 QH aphthous ulcer"H
"""""cancerH """""granuloma
;)o-e"%! -(#"$&om# *$(%"- 8(e-"#"!)6 he 'o(m !o"s%*e(e* #s #
8(e-"#"!) $mo( +e!#$se o' %s eme(-e"!e %" he mo$h#(e#6 ;)o-e"%!
-(#"$&om# 5#&so ,"o" #s E($8%e hem#"-%om#64(#"$%o"
%ss$e
-
8/10/2019 SLE 2008 -1
9/14
H Arythema to[icumbr1b *,* +,-4*- +T*3*- 4-) 4-/)4k 4 -)* ,k4,
,33./4,-*D 4-) -)*,k4, D43/),Tk* H Q o . T4/)..,3 4|*/-4.
+3*D.)@+),* g@ /-T*D4,k.343 QH physiological discharge "H Xandida
infection "
r2b |*,* +,-4*- +T*3*- 4-) -)4/F ,k4, D43/),Tk* /..T .
4-/)4k,k4, *},4,-4. g@ 3+*/ .T, H Q r4,k.343QHphysiological
discharge
rab /,3* 3/*,T4. +,-4*- ). 43 F. /,3* .| )*+,-4-43
*3-4k,-4.3).3Q)4k) ,F,4* +).3+),-*3 ,4.-T,3|*T,3*H3 Ak Q *H3 ,g Q
b*4,k.343Q
Ho,struction of ,iliary tract ##rrb*+4D*4..k4/, 3-D@ |.T 3.F*T
3,4D -)*T* 43 10000 3.F*T 4 -)* ,T*, ,-3-,T- .| -)* 3-D@ -)*T* 43
2000 ,- -)* *D .| -)* 3-D@ -)*T* 43 1000 -)*4/4D*/* .| -)43 3-D@ 43
Q1H 0% 000 0000-H 0%.ncidence proportion Balso ^nown as cumulative
incidenceE is the num,er of new cases within a speciedtime period
divided ,y the si\e of the population initially at ris^" kor
e[ample if a population initially contains000 nonHdiseased persons
and !Z develop a condition over two years of o,servation the
incidenceproportion is !Z cases per 000 persons i"e" !"Z%"
rob *+4D*4..k4/, 3-D@ ,- -. 3** -)* ,*/- .| 3.F4k 4 -)*
gT./).k*4//,T/4., -)*@ 3, -),- 43 0 .| 3.F*T ),3 gT./).k*4/ /,T/4.,
a0 .| . 3.F*T ),3 -)* D43*,3* -)* 3+*/4B/4-@ .| -)* D43*,3* ,3 ,
T43F|,/-.T 43 QH_0%H0%
rb |*,* +,-4*- /.+,44k .| -)4T3-@ DT4F , .- .| ,-*T |T**-T4,-4.
3)* ),3 , )43-.T@ .| D4,k.3*D ,3 g4+.,T 34/* 2 **F 3-,T- 4-) ,
*D4/,-4..| 4-)4H psychogenic polydipsia"H central dia,etes
insipidus"nephrogenic dia,etes insipidus "
ithiumHinduced nephrogenic /. may ,e eectively managed with the
administration of amiloride apotassiumHsparing diuretic often used
in con`unction with thia\ide or loop diuretics"
rb /,3* 3/*,T4. |*,* +,-4*- +T*3*- 4-) .*T ,gD.4, +,4 .T
g,/F+,4
-
8/10/2019 SLE 2008 -1
10/14
2ba D,@ g*|.T* *3-T,-4. -)* 2ba D,@ ,|-*T g*k44k .| 4-
Q4,k.343QHprimary dysmenorrhea"H secondary dysmenorrhea "
r8b*DT@ .* +T*3*- 4-) D4,TT)*, )4k) |**T /)43 .-)*T
+)@34/,*},4,-4. 43 .T, 4/D4k g,/F +,4 43 .T, 4,k.343Q
1H Pyelonephritis"-H -acterial gastroenteritis"XH ziral
gastroenteritis"
rb ,-4*- -,F4k ,-4D*+T*33,- DTk ,*3 .| , DTk /,- T**g*T 4- g-),-
T**g*T 4- , DTk .| )@+*T-*34. -)* ,-4D*+T*33,- DTk ,F* DTk DTk
4-*T,/-4. 4-) .* .| -)* |..4kDTk QH on of the a,ove"
o0b ,-4*- +T*3*- 4-) 3**T gT./)4, ,3-), )4/) .| -)* |..4k
DTk
.- T*/.*D*D -. k4* 4- Q1H Sodium gluconate "-H Xorticosteroid
Bin`ection or orally# EXH Xorticosteroid ne,uli\er"
o1b g,g@ +T*3*- 4-) +,4 4 -)* *,T g@ *},4,-4. -)*T* 43 +4*/* .|
, k,33D**+ 4 )43 *,T /,, -)* .-)*T *-4. , )43-.T@ .| , gT.F* k,33 4
-)*F4-/)* g- 3)* /*, -),- /.+*-*@ * -T*,- -),- g@Q . 4TT4k,-4.1H -y
applying a stream of solution to syringing the ear"-H Remove it ,y
forceps"
o2b C,3* 3/*,T4. g,g@ 2 @*,T3 ,k* +T*3*- 4-) , )43-.T@ .| R ,3,
D43/),Tk* ,|-*T -),-/.+4/,-*D -. )**4k -)*T* 43 T,*3 4 -)* *D
43+4T,-.T@ *,T@*}+4T,-.T@ +),3* +T..k*D *}+4T,-.T@ +),3* 3**T
T*3+4T,-.T@ D43-T*33 34k-)* ,//*33.T@ 3/* 4
T*3+4T,-4.4,k.343Q1Hziral pneumonia"-H-ronchilitis"XH-acterial
pneumonia"
oab M.-)*T gT4k )*T g,g@ -. @. )* )* +T*3*- 4-) )*,-., 4 )43
,4H. -. ,,k* -)43 +,-4*-Q1Ho need things F as^ him to go to the
home"-H,ring a sharp metal B {6 E F press in the middle to evacuate
the bematoma"XHremove the nail"
orb 4 -)* 44-4, *,,-4. |.T 4|*T-44-@Q1H Temperature chart"-H
Semen analysis"XH Refer to reproductive clinic"/H rine analysis to
detect the ovulation "
-
8/10/2019 SLE 2008 -1
11/14
oob34D* **/- .| *.D.+, QH fatal hepatic to[icity "H fatal renal
to[icity"Hdys^inesiaHspeechob +,-4*- +T*3*- -. @. )* @. 3** )43
/,3* @. D43/.*T -),- +,-4*-),3 -*T4, 3-,k* .| /)T.4/ 4*33 ). -.
,,k* -)43 +,-4*- Q
H ma^e him go to the home"ob A |*,-T*3 .| -.34,T ,g3/*33 *}/*+-
Qdeviation of uvula to aected side:
o8bET*-)*, .D.3 Qpainful red nodules treated with S1./s not
steroids
o /)4D 4-) */*, ,T* + )* 43 . 3-*T.4D ,D ),4k 4-/)4k D43-Tg
)433**+4kQ,,k**- Q
H ointmentH antihistamine##b0b+T*k,- ,D@ 28 F3 4-) C),@D4,
4|*/-4. QHa\ithromycin B single dose EHerythromycin B this point
what . remem,er was not present EH /o[ycyclineH ! points of ! drug
of oinolon groupb
1b /.. /,3* .| ,* 4|*T-44-@QHprimary hypogonadisim : ilnfelter
syndrome ||||| turner syndrome in female
Hsecondary hypogonadisimHe`aculation o,struction
2b18@*,T3 .D g.@ 4-) g,/F +,4 4*3-4k,-4. -. D. *}/*+- QCC vASRG
Hray,one scan
ab 4T. D*B/4*/@ ,*4, QHserum iron
HferritinHT.-X
r b )4/) kT.+ @. 4 D. .*T *D.3/.+@ |.T +,-4*-3 4-) 4T.
D*B/4*/@,*4, 4 4-) . g*4k /,3*QHmale all age
groupHchildrenHpermanupausal womenHwomen DXP
ob |*,* +,-4*- F. -. @. 34/* a @*,T3 ,k. ),3 S 3)* D4D-
,kT**
-
8/10/2019 SLE 2008 -1
12/14
4-) @. ,g.- -),- @. D. , -)* 4*3-4k,-4. .-)4k 3kk*3-4* .-)*T
-),-),- 3)* ,- @. -. T*|*T )*T ,- -)43 /,3* ),- @. 4 D.H
""""""""""""""you will response to her F refer her to the doctor
that he is want "H """""""""""you will response to her F refer her
to the doctor that you are want "
b .* .| @.T |*,* +,-4*- ),3 /.+4/,-*D /,3* /.* -. @. k4* )4
.-)*T ,++.4-*- |.T )* )* /,* )*T ,++.4-*- ,3 ,- 10Q00 D4D- 4-*T
-. @. *}/*+- ,- 11Q1o 3)* ,3 ,kT@ g*/,3* .| -),- ),- @.4 D. . QH
Ampathy with the patient F""""""""Hempathy with the patient
F""""""""H """""""""""""""""""" told to the patient you have other
complicated case must inter ,efore you"
b |*,* +,-4*- +T*3*- -. @. /.+,44k .| 3DD* +,T,@343 3)* ),3,
)43-.T@ -),- )3g,D ,.4-*D )*T .T ),++* -),- 4 -)* /44/ v)@34/,
*},4,-4. 4/D4k *T..k4/, *},4,-4. 43 .T,4,k.343Q
HXonversion disorder
HERE S A R CASE RS
H REA HE EE R H EERACE EC SER
~RL H 1R SMERRHEA A LL ~E SAS
4 *3-4. 4 -)4F 4- ,3 *34. -),- -)*T* ,3 3-*,-* *34.vv
+,-4*- /,* 4-) 3/T.-, 3*4k ),- 4*3-k,-4. -. D.QS
-)*T* ,3 , *3-4. ,g.- g,g@ 4-) *,.,Qwide e[ision and follow
uprefer to [email protected] ,D@ 4-) +*4/ +,4 ,D *.TT)k4, *} 3)*D
-*T4* ,33v
D}uterine ,roidadenomyosisendometriosis
g*3- 4}QSlaproscopy
-
8/10/2019 SLE 2008 -1
13/14
-*43 *g. -T*,-*-QS1.S1./s restrict activity ,-*T, *+4/.D@*
H ,,k**- Qo[itocin infusionmesoprosto
,,k**- .| .g*34-@ 4 v 10 @*,T3 g.@Qmultifactorial
.k , 4-) +T43@ g*3- ,,k**-QS1.s
acetaminophencortisone
-)*T* ,g.- +,-4*- 4-) D4,g*-*3 ,D )@+*T -*34. )4/) .* .|
,-4)@+*T-*34* ,D4/,-4. @. ,, ,DD BT3-"1XA!",H,loc^er"caHchannel
,loc^erY"alphaH,lo^er
-)* 4| +,-4*- 3-4 )@+*T-*34* ),- -)* *}-
/).4/*v",H,lo^er!"thia\ide"1R-Y"caHchannel ,loc^er
T*//T*- ,g.T-4. ,- 1 **F .T, |*-3 4-).- ,@ /.k**-,,.,4*43
Hcervical incompetence
,k4, 4-/)4k )4-* D43/),Tk .- .*34*candida
,k4, 4-/)4k )4-* D43/),Tk g .*34*,acteial vaginosis
-
8/10/2019 SLE 2008 -1
14/14
,k*- D43*,3* QH .T, /, ,D +.r )4k) AL
*/),- D43*,3* QPainful ulcer in mouth and gentialia
*3- +T.+)@,}43 |.T 34/F* /* ,*4, QPencillin
Dtitis e[terna : ear tragus painful HHHHDtits media if
persistent eusion kDR months HHH myringotomy
}}}"CA/.X11X1/AC"ATCOLLECTED AND TRIED TO BE ANSWERD AND SENT
BY
DR.ABULMALIK ALBAKER [email protected]=>? FG J PQ
=VX Z[ \ ]X ^V> `aX=VX =V[bc Z dP =fg
mailto:[email protected]:[email protected]
